Chemoinformaics analysis of N-P-Coumaroyltyramine
| Molecular Weight | 283.327 | nRot | 5 |
| Heavy Atom Molecular Weight | 266.191 | nRig | 14 |
| Exact Molecular Weight | 283.121 | nRing | 2 |
| Solubility: LogS | -2.95 | nHRing | 0 |
| Solubility: LogP | 2.588 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 43.2315 |
| nHD | 3 | BPOL | 18.4925 |
| QED | 0.738 |
| Synth | 1.9 |
| Natural Product Likeliness | 0.06 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.136 |
| Pgp-sub | 0.029 |
| HIA | 0.042 |
| CACO-2 | -4.802 |
| MDCK | 0.0000133 |
| BBB | 0.128 |
| PPB | 0.957436 |
| VDSS | 0.641 |
| FU | 0.0311558 |
| CYP1A2-inh | 0.888 |
| CYP1A2-sub | 0.087 |
| CYP2c19-inh | 0.857 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.801 |
| CYP2c9-sub | 0.969 |
| CYP2d6-inh | 0.745 |
| CYP2d6-sub | 0.904 |
| CYP3a4-inh | 0.54 |
| CYP3a4-sub | 0.257 |
| CL | 13.885 |
| T12 | 0.917 |
| hERG | 0.316 |
| Ames | 0.218 |
| ROA | 0.283 |
| SkinSen | 0.942 |
| Carcinogencity | 0.44 |
| EI | 0.235 |
| Respiratory | 0.193 |
| NR-Aromatase | 0.185 |
| Antiviral | Yes |
| Prediction | 0.660445 |